Amoxapine and Zinc sulphate turbidity decreased - a phase IV clinical study of FDA data
Zinc sulphate turbidity decreased is reported only by a few people who take Amoxapine.
The phase IV clinical study analyzes which people take Amoxapine and have Zinc sulphate turbidity decreased. It is created by eHealthMe based on reports of 799 people who have side effects while taking Amoxapine from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
799 people reported to have side effects when taking Amoxapine.
Among them, 2 people (0.25%) have Zinc sulphate turbidity decreased.
What is Amoxapine?
Amoxapine has active ingredients of amoxapine. eHealthMe is studying from 815 Amoxapine users for its effectiveness, alternative drugs and more.
What is Zinc sulphate turbidity decreased?
Zinc sulphate turbidity decreased is found to be associated with 6 drugs and 14 conditions by eHealthMe.
Number of Amoxapine and Zinc sulphate turbidity decreased reports submitted per year:
Gender of people who have Zinc sulphate turbidity decreased when taking Amoxapine *:
- female: 100 %
- male: 0.0 %
Age of people who have Zinc sulphate turbidity decreased when taking Amoxapine *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Common drugs people take besides Amoxapine *:
- Tofranil: 2 people, 100.00%
- Clonazepam: 1 person, 50.00%
Common side effects people have besides Zinc sulphate turbidity decreased *:
- Thrombocythaemia (an increased number of platelets in the circulating blood): 2 people, 100.00%
- Malaise (a feeling of general discomfort or uneasiness): 2 people, 100.00%
- Hepatomegaly (abnormal enlargement of the liver): 2 people, 100.00%
- Haemoglobin Decreased: 2 people, 100.00%
- Haematocrit Decreased: 2 people, 100.00%
- Fever: 2 people, 100.00%
- C-Reactive Protein Increased: 2 people, 100.00%
- The Flu (the flu is caused by an influenza virus): 1 person, 50.00%
- Rash Pruritic (redness with itching): 1 person, 50.00%
- Mean Cell Volume Abnormal (abnormal of the average red blood cell volume): 1 person, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take Amoxapine and have Zinc sulphate turbidity decreased?Check whether Zinc sulphate turbidity decreased is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Zinc sulphate turbidity decreased and when was it recovered:
Expand to all the drugs that have ingredients of amoxapine:
Alternative drugs to, pros and cons of Amoxapine:
- Amoxapine (815 reports)
Zinc sulphate turbidity decreased treatments and more:
- Zinc sulphate turbidity decreased (5 reports)
COVID vaccines that are related to Zinc sulphate turbidity decreased:
- Zinc sulphate turbidity decreased in Moderna COVID Vaccine
- Zinc sulphate turbidity decreased in Pfizer BioNTech Covid Vaccine
- Zinc sulphate turbidity decreased in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Zinc sulphate turbidity decreased:
- Zinc sulphate turbidity decreased (6 drugs)
All the conditions that are associated with Zinc sulphate turbidity decreased:
- Zinc sulphate turbidity decreased (14 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on amoxapine (the active ingredients of Amoxapine) and Amoxapine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Talwin Compound and Exemestane drug interaction - a second ago
- Trazodone Hydrochloride and Breast Lump - a second ago
- Levoxyl and Interstitial Nephritis - 20 seconds ago
- Levoxyl and Nephritis - Interstitial - 20 seconds ago
- Indocin and Paranoia - 22 seconds ago
- Fosinopril Sodium and Reopro drug interaction - 22 seconds ago
- Tazidime and Subcutaneous Haematoma - 42 seconds ago
- Eczema Exacerbated and Acute Myeloid Leukaemia Aggravated - 46 seconds ago
- Hctz and Azopt drug interaction - 56 seconds ago
- Diamox and Obesity Hypoventilation Syndrome (Ohs) - a minute ago